Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) — Financial Flexibility Index
Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has a Financial Flexibility Index of 0.16x as of September 2025. Free cash flow of CN¥170.19 Million (operating CF CN¥88.00 Million minus capex CN¥82.19 Million) represents 0% of total liabilities (CN¥1.04 Billion). Check Guangdong Zhongsheng Pharmaceutical Co L strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Guangdong Zhongsheng Pharmaceutical Co Ltd Financial Flexibility Index (2006–2024)
Historical Financial Flexibility Index trend for Guangdong Zhongsheng Pharmaceutical Co Ltd across 19 annual periods. See working capital to net assets of Guangdong Zhongsheng Pharmaceutical Co L to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
Year-by-year free cash flow to debt coverage for Guangdong Zhongsheng Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 002317 market cap overview.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.37x | CN¥566.10 Million | CN¥337.84 Million | CN¥1.54 Billion | ▲ +28.0% |
| 2023 | 0.29x | CN¥553.67 Million | CN¥190.61 Million | CN¥1.93 Billion | ▲ +69.5% |
| 2022 | 0.17x | CN¥331.03 Million | CN¥63.07 Million | CN¥1.96 Billion | ▼ -72.4% |
| 2021 | 0.61x | CN¥836.53 Million | CN¥622.77 Million | CN¥1.36 Billion | ▲ +140.4% |
| 2020 | 0.26x | CN¥293.37 Million | CN¥138.93 Million | CN¥1.15 Billion | ▼ -7.7% |
| 2019 | 0.28x | CN¥379.49 Million | CN¥251.16 Million | CN¥1.37 Billion | ▼ -23.9% |
| 2018 | 0.36x | CN¥470.26 Million | CN¥326.78 Million | CN¥1.29 Billion | ▼ -17.2% |
| 2017 | 0.44x | CN¥494.19 Million | CN¥369.91 Million | CN¥1.13 Billion | ▼ -26.6% |
| 2016 | 0.60x | CN¥479.47 Million | CN¥338.28 Million | CN¥801.23 Million | ▲ +172.6% |
| 2015 | 0.22x | CN¥268.82 Million | CN¥192.25 Million | CN¥1.22 Billion | ▼ -70.2% |
| 2014 | 0.74x | CN¥300.14 Million | CN¥100.60 Million | CN¥407.63 Million | ▼ -21.4% |
| 2013 | 0.94x | CN¥222.85 Million | CN¥110.95 Million | CN¥238.04 Million | ▼ -35.9% |
| 2012 | 1.46x | CN¥219.80 Million | CN¥142.38 Million | CN¥150.41 Million | ▼ -47.2% |
| 2011 | 2.77x | CN¥255.96 Million | CN¥70.56 Million | CN¥92.54 Million | ▲ +66.5% |
| 2010 | 1.66x | CN¥158.74 Million | CN¥91.72 Million | CN¥95.53 Million | ▲ +45.7% |
| 2009 | 1.14x | CN¥123.73 Million | CN¥100.89 Million | CN¥108.46 Million | ▲ +76.1% |
| 2008 | 0.65x | CN¥92.35 Million | CN¥72.86 Million | CN¥142.53 Million | ▲ +44.4% |
| 2007 | 0.45x | CN¥75.02 Million | CN¥49.35 Million | CN¥167.17 Million | ▲ +147.3% |
| 2006 | 0.18x | CN¥27.75 Million | CN¥17.91 Million | CN¥152.93 Million | — |